| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 52856-501-01 | 52856-501 | HUMAN PRESCRIPTION DRUG | EMFLAZA | deflazacort | TABLET | ORAL | 20180910 | N/A | NDA | NDA208684 | PTC Therapeutics, Inc. | DEFLAZACORT | 6 mg/1 | 100 TABLET in 1 BOTTLE (52856-501-01) |
| 52856-503-03 | 52856-503 | HUMAN PRESCRIPTION DRUG | EMFLAZA | deflazacort | TABLET | ORAL | 20180910 | N/A | NDA | NDA208684 | PTC Therapeutics, Inc. | DEFLAZACORT | 30 mg/1 | 30 TABLET in 1 BOTTLE (52856-503-03) |
| 52856-504-03 | 52856-504 | HUMAN PRESCRIPTION DRUG | EMFLAZA | deflazacort | TABLET | ORAL | 20180910 | N/A | NDA | NDA208684 | PTC Therapeutics, Inc. | DEFLAZACORT | 36 mg/1 | 30 TABLET in 1 BOTTLE (52856-504-03) |
| 52856-502-03 | 52856-502 | HUMAN PRESCRIPTION DRUG | EMFLAZA | deflazacort | TABLET | ORAL | 20180910 | N/A | NDA | NDA208684 | PTC Therapeutics, Inc. | DEFLAZACORT | 18 mg/1 | 30 TABLET in 1 BOTTLE (52856-502-03) |